Ionis Pharmaceuticals, Inc. (IONS)
81.78
-2.57
(-3.05%)
USD |
NASDAQ |
Feb 12, 16:00
81.83
+0.05
(+0.06%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash from Investing (Quarterly) : 91.34M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -1.232B |
| Eli Lilly & Co. | -- |
| Johnson & Johnson | -4.485B |
| Merck & Co., Inc. | -- |
| Cogent Biosciences, Inc. | -155.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -131.44M |
| Cash from Financing (Quarterly) | 81.22M |
| Free Cash Flow | -309.48M |
| Free Cash Flow Per Share (Quarterly) | -0.8661 |
| Free Cash Flow to Equity (Quarterly) | -212.24M |
| Free Cash Flow to Firm (Quarterly) | -116.17M |
| Free Cash Flow Yield | -2.30% |